Translation of Stroke Specific Quality of Life Questionnaire Into Local Languages of Pakistan
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Apr 12, 2021
Trial Information
Current as of May 03, 2025
Unknown status
Keywords
ClinConnect Summary
The stroke-Specific Quality of Life Scale is regarded as one of the most extensive and more commonly utilized patient-centred and self-reported measure of outcomes in the stroke population. The SS-QoL scale is a health-related outcome measure that comprises 49 items in 12 areas of vision, mobility, thinking, social roles, self-care, language, personality, family roles, work/productivity, upper limb function, mood and energy. It covers a more extensive inclusion of capacities ordinarily influenced by stroke.
The Stroke Specific Quality of Life questionnaire, originally developed in English,...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients post-stroke (sub-acute/chronic stage)
- • Participants belonging to Urdu, Punjabi, Sindhi, Balochi and Pashto speaking class
- • Patients should be capable to complete the questionnaire without any help.
- Exclusion Criteria:
- • Healthy population
- • Patients at the acute stage of stroke/ TIA.
- • Individuals diagnosed with conditions other than stroke.
- • Individuals with language/ memory problems.
- • Individuals with disability due to any structural/congenital cause.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Abbottabad, Kpk, Pakistan
Patients applied
Trial Officials
Imran Amjad, PhD
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials